Literature DB >> 22388657

Neural stem cells for spinal cord repair.

Beatrice Sandner1, Peter Prang, Francisco J Rivera, Ludwig Aigner, Armin Blesch, Norbert Weidner.   

Abstract

Spinal cord injury (SCI) causes the irreversible loss of spinal cord parenchyma including astroglia, oligodendroglia and neurons. In particular, severe injuries can lead to an almost complete neural cell loss at the lesion site and structural and functional recovery might only be accomplished by appropriate cell and tissue replacement. Stem cells have the capacity to differentiate into all relevant neural cell types necessary to replace degenerated spinal cord tissue and can now be obtained from virtually any stage of development. Within the last two decades, many in vivo studies in small animal models of SCI have demonstrated that stem cell transplantation can promote morphological and, in some cases, functional recovery via various mechanisms including remyelination, axon growth and regeneration, or neuronal replacement. However, only two well-documented neural-stem-cell-based transplantation strategies have moved to phase I clinical trials to date. This review aims to provide an overview about the current status of preclinical and clinical neural stem cell transplantation and discusses future perspectives in the field.

Entities:  

Mesh:

Year:  2012        PMID: 22388657     DOI: 10.1007/s00441-012-1363-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  22 in total

Review 1.  Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?

Authors:  John Bianco; Pauline De Berdt; Ronald Deumens; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2016-01-14       Impact factor: 9.261

Review 2.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 3.  Current status of cell-mediated regenerative therapies for human spinal cord injury.

Authors:  Tongming Zhu; Qisheng Tang; Huasong Gao; Yiwen Shen; Luping Chen; Jianhong Zhu
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

4.  Axonal alignment and enhanced neuronal differentiation of neural stem cells on graphene-nanoparticle hybrid structures.

Authors:  Aniruddh Solanki; Sy-Tsong Dean Chueng; Perry T Yin; Rajesh Kappera; Manish Chhowalla; Ki-Bum Lee
Journal:  Adv Mater       Date:  2013-07-04       Impact factor: 30.849

5.  Micropattern-based nerve guidance conduit with hundreds of microchannels and stem cell recruitment for nerve regeneration.

Authors:  DoYeun Park; Donghak Kim; Su Jeong Park; Jeong Ho Choi; Yoojin Seo; Dong-Hwee Kim; Sang-Hoon Lee; Jung Keun Hyun; Jin Yoo; Youngmee Jung; Soo Hyun Kim
Journal:  NPJ Regen Med       Date:  2022-10-20

6.  Electrical stimulation of embryonic neurons for 1 hour improves axon regeneration and the number of reinnervated muscles that function.

Authors:  Yang Liu; Robert M Grumbles; Christine K Thomas
Journal:  J Neuropathol Exp Neurol       Date:  2013-07       Impact factor: 3.685

7.  Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats.

Authors:  Xiaofei Wang; Xiao-Ming Xu
Journal:  Exp Neurol       Date:  2014-05-27       Impact factor: 5.330

Review 8.  [Novel aspects of diagnostics and therapy of spinal cord diseases].

Authors:  R Rupp; A Blesch; L Schad; B Draganski; N Weidner
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 9.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

10.  Bone marrow mesenchymal stem cells stimulated with low-intensity pulsed ultrasound: Better choice of transplantation treatment for spinal cord injury: Treatment for SCI by LIPUS-BMSCs transplantation.

Authors:  Guang-Zhi Ning; Wen-Ye Song; Hong Xu; Ru-Sen Zhu; Qiu-Li Wu; Yu Wu; Shi-Bo Zhu; Ji-Qing Li; Man Wang; Zhi-Gang Qu; Shi-Qing Feng
Journal:  CNS Neurosci Ther       Date:  2018-10-08       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.